Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.

Experimental & molecular medicine·2026
Same author

Germline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study.

Oncology research·2026
Same author

Seroprevalence of Japanese Encephalitis Virus, and Immunogenicity of the Vero-Cell Culture-Derived Vaccine in Hematopoietic Stem Cell Transplantation Recipients.

Journal of Korean medical science·2026
Same author

Assessing Palliative Care Needs Among Adolescent and Young Adult Patients with Cancer and Their Caregivers in South Korea.

Journal of adolescent and young adult oncology·2026
Same author

Fate of Brain Metastasis With Cerebrospinal Fluid Space Invasion Based on MRI Findings: Clinical Features and Factors Affecting Progression to Overt Leptomeningeal Metastasis.

Brain tumor research and treatment·2026
Same author

Trends in Incidence and Survival of Childhood and Adolescent Cancer in Korea, 2001-2020: Comparison with U.S. SEER Data.

Cancer research and treatment·2026

Related Experiment Video

Updated: Feb 17, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K

Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).

Ho-Shin Gwak1, Hyeon Jin Park1

  • 1Department of System Cancer Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea; Center for Pediatric Cancer, National Cancer Center, Goyang, Republic of Korea.

Critical Reviews in Oncology/Hematology
|December 5, 2017
PubMed
Summary

Diffuse intrinsic pontine glioma (DIPG) has a poor prognosis, with limited treatment options. New genomic insights and targeted therapies show promise for improving outcomes in this challenging pediatric brain tumor.

Keywords:
BiopsyBrainstem gliomaChemotherapyDiffuse pontine intrinsic gliomaMolecular targeted therapy

More Related Videos

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

980
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.9K

Related Experiment Videos

Last Updated: Feb 17, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

980
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.9K

Area of Science:

  • Pediatric neuro-oncology
  • Molecular pathology of brain tumors
  • Genomic analysis of gliomas

Background:

  • Diffuse intrinsic pontine glioma (DIPG) presents a dismal prognosis, with median survival around 10 months post-radiation.
  • Current chemotherapy offers limited benefits beyond radiation therapy for DIPG.
  • DIPG molecular profiles differ significantly from supratentorial high-grade gliomas.

Purpose of the Study:

  • To review advances in understanding DIPG biology and treatment strategies.
  • To highlight the potential of new therapeutic approaches for DIPG.
  • To discuss the implications of the WHO classification on DIPG research.

Main Methods:

  • Genomic analyses and molecular profiling of autopsy specimens.
  • Examination of combined cytotoxic and targeted inhibitor treatments in ongoing trials.
  • Utilizing spontaneous DIPG mouse models for preclinical studies.
  • Investigating convection-enhanced delivery for direct brainstem drug infusion.

Main Results:

  • Biotechnology advances allow for detailed genomic and molecular characterization of DIPG.
  • New DIPG mouse models facilitate preclinical therapeutic evaluations.
  • Convection-enhanced delivery offers a potential route for localized drug delivery to the brainstem.
  • The WHO classification identifies diffuse midline gliomas with H3-K27M-mutation, aiding DIPG identification.

Conclusions:

  • Genomic insights into DIPG are crucial for developing targeted therapies.
  • Combined treatment strategies and novel drug delivery methods show therapeutic potential.
  • Accurate tissue confirmation and molecular profiling are key to advancing DIPG treatment and improving patient survival.